Karbinal ER and Pregnancy
No research has been done on using Karbinal ER (carbinoxamine extended-release oral suspension) during pregnancy in humans or animals. Therefore, it is unknown if this drug is safe to use for women who are pregnant. Due to the uncertainty, this product should only be prescribed to a pregnant woman if the benefits of using the drug outweigh any potential risks to the unborn child.
Can Pregnant Women Take Karbinal ER?
Karbinal™ ER (carbinoxamine extended-release oral suspension) is a prescription medication approved to treat allergies. It belongs to a general group of medicines known as antihistamines. Karbinal ER may not be safe to take during pregnancy, although the full risks are currently unknown.
What Is Pregnancy Category C?
The U.S. Food and Drug Administration (FDA) uses a category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Karbinal ER is classified as a pregnancy Category C medicine.
Pregnancy Category C is given to medicines that have not been studied in pregnant humans but appear to cause harm to the fetus in animal studies. Medicines that have not been studied in any pregnant women or animals are automatically given a pregnancy Category C rating.
Karbinal ER was given a pregnancy Category C rating because it has not been studied in pregnant women or animals. Therefore, it is not known whether Karbinal ER harms an unborn child. It is also not known whether this drug affects labor and delivery.
However, a pregnancy Category C medicine may be given to a pregnant woman if her healthcare provider believes that the benefits to the woman outweigh any possible risks to her unborn child.
If you are pregnant or thinking about becoming pregnant, let your healthcare provider know before taking Karbinal ER. He or she will consider the benefits and risks before making a recommendation in your particular situation.